Role of Serum Midkine Level as a Diagnostic Biomarker for Very Early and Early Hepatocellular Carcinoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21608/AEJI.2017.10599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma

  2015cited by this paper
• Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients

  2013cited by this paper
• Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma

  2013cited by this paper
• Serum midkine as a prognostic biomarker for patients with hepatocellular carcinoma.

  2011cited by this paper
• Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.

  2011cited by this paper
• Tailoring of Interventional Procedures for HCC Patients-Review Article

  2010cited by this paper
• Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics

  2009cited by this paper
• Modern diagnosis and management of hepatocellular carcinoma.

  2009cited by this paper
• Midkine in plasma as a novel breast cancer marker

  2009cited by this paper
• Midkine mRNA Is Overexpressed in Pancreatic Cancer

  2009cited by this paper
• Midkine as a prognostic biomarker in oral squamous cell carcinoma

  2008cited by this paper
• Plasma midkine level is a prognostic factor for human neuroblastoma

  2008cited by this paper
• Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

  2008cited by this paper
• Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma

  2007cited by this paper
• Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.

  2006cited by this paper
• Management of hepatocellular carcinoma

  2005cited by this paper
• Hepatocellular carcinoma in Egypt: a single center study over a decade.

  2005cited by this paper
• Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma

  2003cited by this paper
• Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis.

  2002cited by this paper
• Tumour markers of hepatocellular carcinoma

  1989cited by this paper
• Cancer statistics

  1989cited by this paper

• Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker

  2024cites this paper